NCT04004364 Early-Phase Schizophrenia: Practice-based Research to Improve Outcomes
| NCT ID | NCT04004364 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Northwell Health |
| Condition | First Episode Psychosis |
| Study Type | OBSERVATIONAL |
| Enrollment | 700 participants |
| Start Date | 2020-04-01 |
| Primary Completion | 2025-03-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 700 participants in total. It began in 2020-04-01 with a primary completion date of 2025-03-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The goal if the project is to develop a learning health network devoted to the treatment of first episode psychosis.
Eligibility Criteria
Inclusion Criteria: * Enrolled in CSC program Exclusion Criteria: * none
Contact & Investigator
Frequently Asked Questions
Who can join the NCT04004364 clinical trial?
This trial is open to participants of all sexes, aged 15 Years or older, up to 40 Years, studying First Episode Psychosis. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT04004364 currently recruiting?
Yes, NCT04004364 is actively recruiting participants. Contact the research team at pmarcy@northwell.edu for enrollment information.
Where is the NCT04004364 trial being conducted?
This trial is being conducted at Lauderdale Lakes, United States.
Who is sponsoring the NCT04004364 clinical trial?
NCT04004364 is sponsored by Northwell Health. The trial plans to enroll 700 participants.